| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $83.8M | -32.6% |
| SG&A Expense | $147.2M | -20.8% |
| Operating Income | -$291.3M | -3295.8% |
| Interest Expense | $11.7M | -31.5% |
| Pre-tax Income | -$534.4M | +39.0% |
| Income Tax | $2.0M | +81.6% |
| Net Income | -$536.4M | -6240.7% |
| EPS (Basic) | -$1.16 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $503.6M | — |
| Short-term Investments | $25.6M | — |
| Inventory | $0 | -100.0% |
| Total Assets | $905.6M | +220.3% |
| Total Liabilities | $783.0M | +4952.3% |
| Stockholders' Equity | $122.6M | +495.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$159.7M | — |
| Capital Expenditures | $456K | -96.1% |
| Investing Cash Flow | -$38.6M | -11.6% |
| Financing Cash Flow | $381.4M | — |
| Free Cash Flow | -$160.2M | -1142.9% |
| +61.5% |
| EPS (Diluted) | -$1.16 | +61.5% |